Also trades as: SLXNW (NASDAQ) · $vol 0M
SLXN NASDAQ
Silexion Therapeutics Ltd.
1W: -0.1%
1M: -26.0%
3M: -90.9%
YTD: -86.2%
1Y: -93.1%
$0.26
-0.02 (-6.85%)
Weekly Expected Move ±34.0%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$11M
-28.9% ▼
Capital Expenditures
$9K
+59.1% ▲
Free Cash Flow
-$11M
-28.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$5M
+242.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$755K | -$3M | -$5M | -$17M | -$12M |
| Depreciation & Amort. | $0 | $57K | $45K | $25K | $14K |
| Stock-Based Comp. | $0 | $125K | $130K | $6M | $134K |
| Change in Working Capital | -$470K | $239K | $87K | -$2M | $601K |
| Other Non-Cash Items | -$182K | -$268K | $317K | $4M | $344K |
| Operating Cash Flow | -$1M | -$3M | -$5M | -$8M | -$11M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$40K | -$12K | -$22K | -$9K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | -$500K | $0 | $0 | -$5K |
| Investment Sales | $0 | $16K | $507K | $0 | $0 |
| Other Investing | $0 | $0 | $78K | $0 | $0 |
| Investing Cash Flow | $0 | -$524K | $573K | -$22K | -$14K |
| — Financing Activities — | |||||
| Net Debt Issuance | $150K | $0 | $0 | -$250K | -$696K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$3M | $3K | $0 | $2M | $0 |
| Financing Cash Flow | $116M | $3M | $522K | $5M | $16M |
| Net Change in Cash | -$13K | -$2M | -$4M | -$3M | $5M |
| Cash End of Period | $39K | $8M | $5M | $1M | $6M |
| Free Cash Flow | -$1M | -$3M | -$5M | -$8M | -$11M |